Semi-Preparative High Performance Liquid Chromatographic Separation of Carbon-14 Labeled Avermectin B1a from a Mixture of Avermectins

Abstract

A semi-preparative high performance liquid chromatographic method has been developed to separate carbon-14 labeled avermectin B_1a from a fermentation mixture of carbon-14 labeled avermectins, i. e., avermectins A₁a, A₁b, A₂a, A₂b, B₁a, B₁b, B₂a, and B₂b. Two HPLC systems were employed for the separation: I. A Whatman M20, Partisil 10, normal phase column and a solvent system of 10% ethanol in isooctane (v/v), and II. A Whatman M20, Partisil 10, ODS-3, reverse phase column and a solvent system of acetonitrile/methanol/water (56:18:26, v/v/v); the flow rate was 18 ml/ min. Avermectin separations were monitored using ultraviolet detection (254 nm). Further analyses of avermectin B₁a were done using analytical HPLC and TLC/radioassay to check compound purity and identity.     

Liquid Chromatographic Analysis of Pentobarbital

Abstract

A method is described for a one step acetonitrile precipitation of serum or plasma and subsequent analysis of pentobarbital by reverse phase HPLC. The results of using two internal standards, N,N-Diethyl-m-toluamide and 5-(p-Methylphenyl)-5-phenylhydantoin are compared. Internal standard is added to serum (as little as 25 μL) and vortex-mixed with acetonitrile followed by centrifugation. An aliquote of the supernatant is analyzed on a C18 reverse phase column eluted with metanol/0.05 M (NH₄)₂HPO₄, pH 8/water (55/20/25, v/v/v). The effluent is monitored at 220 nm.     

HPLC‐UV Detection for Analysis of p‐Benzoquinone Dioxime and p‐Nitrosophenol,and Chromatographic Fingerprint Applied in Quality Control of Industrial p‐Benzoquinone Dioxime

Abstract

A reliable reversed‐phase high performance liquid chromatographic (HPLC) method has been developed for simultaneous determination of p‐benzoquinone dioxime (BQD) and its related impurity p‐nitrosophenol (NSP). Separation was achieved on a Kromasil C₁₈ column by using methanol‐water‐NH₄Ac‐NH₃ solution (pH=7.0, 50 mM) (30/50/20, v/v/v) as the mobile phase, and detection was operated by UV absorption at a wavelength of 305 nm. The method was seen to have good linearity, accuracy, and precision for the concentration range and to be an attractive choice for the quality control of BQD for industrial use. Moreover, the HPLC‐UV‐vis fingerprint of BQD has been established, and successfully applied to quality control of industrial BQD in laboratories of some rubber factories in China. Chromatographic fingerprints of intermediates would become an effective strategy for accelerating the progress of fine chemical industry.     

Stability-Indicating Chromatographic Methods for Simultaneous Determination of Mosapride and Pantoprazole in Pharmaceutical Dosage Form and Plasma Samples

Simple, sensitive, selective, precise, and stability-indicating thin-layer chromatography (TLC) and high-performance liquid chromatography (HPLC) methods for the determination of mosapride and pantoprazole in pharmaceutical tablets were developed and validated as per the International Conference on Harmonization guidelines. The TLC method employs aluminum TLC plates precoated with silica gel 60F₂₅₄ as the stationary phase and ethyl acetate/methanol/toluene (4:1:2, v/v/v) as the mobile phase to give compact spots for mosapride (R _f 0.73) and pantoprazole (R _f 0.45) separated from their degradation products; the chromatogram was scanned at 276 nm. The HPLC method utilizes a C18 column and a mobile phase consisting of acetonitrile/methanol/20 mM ammonium acetate (4:2:4, v/v/v) at a flow rate of 1.0 mL min⁻¹ for the separation of mosapride (t _R 11.4) and pantoprazole (t _R 4.4) from their degradation products. Quantitation was achieved with UV detection at 280 nm. The same HPLC method was successfully used in performing calibrations in lower concentration ranges for both drugs in human plasma using ezetimibe as internal standard. The methods were validated in terms of accuracy, precision, linearity, limits of detection, and limits of quantification. Mosapride and pantoprazole were exposed to acid hydrolysis and then analyzed by the proposed methods. As the methods could effectively separate the drugs from their degradation products, these techniques can be employed as stability-indicating methods that have been successively applied to pharmaceutical formulations without interference from the excipients. Moreover the HPLC method was successfully used in the determination of both drugs in spiked human plasma.

     

Stability-Indicating Chromatographic Methods for Simultaneous Determination of Mosapride and Pantoprazole in Pharmaceutical Dosage Form and Plasma Samples

Simple, sensitive, selective, precise, and stability-indicating thin-layer chromatography (TLC) and high-performance liquid chromatography (HPLC) methods for the determination of mosapride and pantoprazole in pharmaceutical tablets were developed and validated as per the International Conference on Harmonization guidelines. The TLC method employs aluminum TLC plates precoated with silica gel 60F₂₅₄ as the stationary phase and ethyl acetate/methanol/toluene (4:1:2, v/v/v) as the mobile phase to give compact spots for mosapride (R _f 0.73) and pantoprazole (R _f 0.45) separated from their degradation products; the chromatogram was scanned at 276 nm. The HPLC method utilizes a C18 column and a mobile phase consisting of acetonitrile/methanol/20 mM ammonium acetate (4:2:4, v/v/v) at a flow rate of 1.0 mL min^?1 for the separation of mosapride (t _R 11.4) and pantoprazole (t _R 4.4) from their degradation products. Quantitation was achieved with UV detection at 280 nm. The same HPLC method was successfully used in performing calibrations in lower concentration ranges for both drugs in human plasma using ezetimibe as internal standard. The methods were validated in terms of accuracy, precision, linearity, limits of detection, and limits of quantification. Mosapride and pantoprazole were exposed to acid hydrolysis and then analyzed by the proposed methods. As the methods could effectively separate the drugs from their degradation products, these techniques can be employed as stability-indicating methods that have been successively applied to pharmaceutical formulations without interference from the excipients. Moreover the HPLC method was successfully used in the determination of both drugs in spiked human plasma.     

A derivative UV spectrophotometric method for the determination of levothyroxine sodium in tablets

A derivative UV (D-UV) spectrophotometric method was developed for the determination of Levothyroxine Sodium (L-T₄) in tablets of different doses. Quantification was performed using the second derivative of the absorption spectrum at 253 nm (²D₂₅₃) in methanol: water (50: 50; v/v) (pH 11.2). The method was validated and compared with an HPLC procedure carried out using a RP-18 column (125 × 4 mm, 5 μm) and methanol: phosphoric acid (0.1%) (70: 30, v/v) (pH 3) as mobile phase. Flow rate was set at 1.5 mL/min, and detection was performed at 225 nm. The proposed D-UV method was linear in the range 3.0–40.0 μg/mL with an appropriate precision and accuracy, and it was selective for the drug under study. On the other hand, results obtained by ²D₂₅₃ analysis were similar to those obtained by HPLC, with no statistically significant differences between them. Therefore, it was concluded that the developed method is suitable for the determination of L-T₄ in tablets at the tested doses.     

Simultaneous Analysis of Cimetidine and Ranitidine in Human Plasma by HPLC

Abstract

A rapid method for the simultaneous quantitation of the H₂-receptor antagonist drugs cimetidine and ranitidine in human plasma by isocratic ion-pair reverse-phase HPLC is described. The method involves a simple organic extraction step of the alkalinized plasma containing added internal standard followed by back extraction of the extract with dilute acetic acid and subsequent analysis of the aqueous acidic phase on a reverse-phase (C18) column. The eluting solvent was acetonitrile-water (20:80 v/v) containing 0.005 mole/litre octanesulphonic acid and was monitored at 229 nm. The run time for the assay was 12.5 minutes, with a detection limit for cimetidine of 50 ng/m1/(0.2 μmole/1) and that for ranitidine was 20 ng/ml (0.06 umole/1).     

High-Performance Liquid Chromatography of Domoic Acid,a Marine Neurotoxin,with Application to Shellfish and Plankton

Abstract

A recent outbreak of poisoning resulting from the consumption of cultured blue mussels (Mytilus edulis L.) from a localized area in Eastern Canada has been attributed to the presence of domoic acid (1), a relatively rare neurotoxic amino acid, previously found only in some algae of the family Rhodomelaceae. Studies on aqueous extracts of shellfish tissue indicated that the toxin and several of its isomers could be separated (and isolated in sufficient amounts for subsequent structural identification) by reversed-phase high-performance liquid chromatography (HPLC) with ultraviolet (UV) diode array detection (DAD). Aqueous acetonitrile containing 0.1% v/v trifluoroacetic acid was used as mobile phase. As the retention time and characteristic UV absorption spectrum of 1 (λ_max = 242 nm) permit unequivocal identification, the HPLC-DAD procedure was refined with a microbore column to provide a rapid (5 min), sensitive (0.3 ng detection limit) and reproducible assay method for the determination of 1 in shellfish tissue. Extraction was accomplished by boiling homogenized shellfish tissue for 5 min with distilled water. Extracts were taken through an octadecylsilica solid phase extraction clean-up prior to HPLC. This method has been applied to a variety of shellfish and phytoplankton samples.

BRIEF

Reversed-phase HPLC with ultraviolet diode array detection was used to analyze shellfish tissue and phytoplankton extracts for domoic acid. A rapid (5 min) and sensitive (0.3 ng detection limit) assay is presented.     

High-Performance Liquid Chromatographic Determination of SAZ-VII-23, A Novel Antiarrhythmic Agent,in Dog Plasma and Urine

Abstract

A HPLC method has been developed to determine the concentrations of SAZ-VII-23 (3-benzoyl-7-isopropyl-3,7-diazabicyclo[3.3.1]nonane HClO₄), a novel antiarrhythmic agent, in dog plasma and urine. Plasma treated with acetonitrile and alkalinized urine were extracted with chloroform- propanol (9:1). An aliquot was injected on to HPLC system using a C₆ reversed-phase column and acetonitrile-methanol-37.5 mM phosphate buffer, pH 6.8 (28.5:28.5:43 v/v) containing 4.0 mM triethylamine as mobile phase. Detection wavelength was 255 nm. The linear range were 0.04–8 μg/ml, and the lower limit of quantitation was 0.04 μg/ml in plasma and urine, respectively. The method was applied to determine plasma and urine concentrations and preliminary pharmacokinetic profiles of SAZ-VII-23 in a dog.     

Chromatographic methods development,validation and degradation characterization of the antithyroid drug Carbimazole

The current paper reports the development and validation of stability‐indicating HPLC and HPTLC methods for the separation and quantification of main impurity and degradation product of Carbimazole. The structures of the degradation products formed under stress degradation conditions, including hydrolytic and oxidative, photolytic and thermal conditions, were characterized and confirmed by MS and IR analyses. Based on the characterization data, the obtained degradation product from hydrolytic conditions was found to be methimazole—impurity A of Carbimazole as reported by the British Pharmacopeia and the European Pharmacopeia. A stability‐indicating HPLC method was carried out using a Zorbax Eclipse Plus CN column (150 × 4.6 mm i.d, 5 μm particle size) and a mobile phase composed of acetonitrile–0.05 m KH₂PO₄ (20: 80, v/v) in isocratic elution, at a flow rate of 1 mL/min. The method was proved to be sensitive for the determination down to 0.5% of Carbimazole impurity A. Additionally, a stability‐indicating chromatographic HPTLC method was achieved using cyclohexane–ethanol (9:1, v/v) as a developing system on HPTLC plates F₂₅₄ with UV detection at 225 nm. The proposed HPLC and HPTLC methods were successfully applied to Carbimazole^® tablets with mean percentage recoveries of 100.12 and 99.73%, respectively.     

Determination of tetraiodothyronine in serum by HPLC and electrochemical detection

Tetraiodo-L -thyronine (T4) in human serum was determined by HPLC using a nonphysiological internal standard. For sample preparation, a cation exchange resin, RP-chromatography on C-18 or phenylphase, and electrochemical detection (Metrohm 656 or BAS-LC 4 A) were employed. The mobile phase (0.8 ml/min) was 10 mM H₃PO₄/CH₃OH (40/60 v/v) or 10 mM H₃PO₄/CH₃CN (70/30 v/v, 1.5 ml/min), the voltage applied 800 mV. The coefficient of variation (day to day) was 6.8% (N = 40); concentrations of T4 found were 11 to 20% lower than those obtained by two different commercially available immunoassays.     

Estimation of Alprazolam and Sertraline in Pure Powder and Tablet Formulations by High-Performance Liquid Chromatography and High-Performance Thin-Layer Chromatography

Abstract

This article describes validated high-performance liquid chromatographic (HPLC) and high-performance thin-layer chromatographic (HPTLC) methods for simultaneous estimation of alprazolam (ALZ) and sertraline (SER) in pure powder and tablet formulation. The HPLC separation was achieved on a Nucleosil C18 column (150 mm long, 4.6 mm i.d., and 5-µm particle size) using acetonitrile and phosphate buffer (50 + 50 v/v), pH 5.5, as the mobile phase at a flow rate of 1.0 mL/min at ambient temperature. The HPTLC separation was achieved on an aluminum-backed layer of silica gel 60 F₂₅₄ using acetone/toluene/ammonia (6.0:3.0:1.0, v/v/v) as the mobile phase. Quantification with the HPLC method was achieved with ultraviolet (UV) detection at 230 nm over the concentration range 3–18 µg/mL for both drugs with mean recovery of 101.86 ± 0.21 and 100.57 ± 0.31% for ALZ and SER, respectively. Quantification in HPTLC was achieved with UV detection at 230 nm over the concentration range of 400–1400 ng/spot for both drugs with mean recoveries of 101.32 ± 0.15 and 100.38 ± 0.51% for ALZ and SER, respectively. These methods are rapid, simple, precise, sensitive, and are applicable for the simultaneous determination of ALZ and SER in pure powder and formulations.     

Determination of Ascorbic Acid and Dehydroascorbic Acid in Blood Plasma Samples

Abstract

Following the stabilization of the plasma samples with HClO₄ and EDTA, the samples could be directly analyzed by HPLC using electrochemical detection and reversed-phase columns. The accuracy and precision of the method was evaluated using plasma samples spiked with ascorbic acid (10 μg/ml) and the results were also compared to the classical colorimetric procedure. Dehydroascorbic (5 μg/ml) was determined in plasma samples using UV detection following derivatization at room temperature for 45 minutes with o-phenylenediamine.     

A New Method for the HPLC Analysis of Pt(II) in Urine

Abstract

An analytical method has been developed to measure Pt(II) in urine via derivatization and UV or HPLC analysis. A measured quantity of urine is heated briefly with diethyl ammonium diethyl-dithiocarbamate, and the resulting Pt(Et₂NCS₂)₂ is extracted into a measured volume of chloroform. Concentrations of Pt(II) are determined by UV absorption at 346 nm or by reverse phase HPLC analysis. The detection limit for Pt(II) as its dithiocarbamate is ～ 1 ng by HPLC; the concentration limit for HPLC analysis by direct extraction was ～ 25 ng/ml. Chromatographic response was linearly related to Pt(II) concentration over the range 100-4, 000 ng/ml; dilution of more concentrated samples has extended this range to at least 30, 000 ng/ml. This method has been applied to the analysis of Pt(II) in the urine of patients who have received cis-dichlorodiamniineplatinum(II) (CDDP) chemotherapy.     

High Performance Liquid Chromatographic Determination of Amiodarone in Plasma and Tissues

Abstract

A simple and rapid high-performance liquid chromatographic (HPLC) method for the determination of amiodarone (AD) in plasma and tissues was developed. The method involved deproteinization of plasma or homogenized tissue with acetonitrile containing an internal standard (N-Cetylpyridinium chloride) followed by reversed phase chromatography using μ bondapack C₁₈ column (10μm) with a mobile phase consisting of acetonitrile - methanol - sodium dihydrogen phosphate buffer (70:10:20%, v/v), the pH adjusted to 4.0 and pumped at flow rate of 1.0 ml/min. The column effluent was monitored at 242 nm. A linear relationship was obtained between peak height ratios (drug to internal standard) versus drug levels over the concentration range of 50–750 ng/ml. The detection limit of AD in plasma and tissues by this method was 20 ng/ml.     

Combined Liquid Chromatography-Mas Spectrometry for Microscale Structural Studies of Carbohydrates

Abstract

Combined HPLC-thermospray was spectrometry of mono-and disaccharides, 1-0-methylglycosides and 0-permethy mono - through tetrasaccharicdes has been studied to asess the potential role of thermospray ionization for microscale structural studies of saccharides and glycoconjugates, and for high sensitivity detection of liquid chromatographic effluents. Using NH₄CO₂H as evaluant for reversed-phase HPLC, abundant MNH₄ ⁴ ions are formed form monosaccharides and mono-and per-methylated saccharides, and are suitable formonitoring sub-nanogram constituents in HPLC effluents. Detection of 100 pg (0.5pmole) of 1-0-methylhexopy-ranosides with signal/noise> 10 is demonstrated.     

Analysis of Aromatic Amines in Surface Waters Receiving Wastewater from a Textile Industry by Liquid Chromatographic with Electrochemical Detection

Abstract

A high performance liquid chromatography (HPLC) method with electrochemical detection (ED) was developed for the determination of benzidine, 3,3‐dimethylbenzidine, o‐toluidine and 3,3‐dichlorobenzidine in the wastewater of the textile industry. The aromatic amines were eluted on a reversed phase column Shimadzu Shimpack C₁₈ using acetonitrile+ammonium acetate (1×10^?4 mol L^?1) at a ratio 46:54 v/v as mobile phase, pumped at a flow rate of 1.0 mL min^?1. The electrochemical oxidation of the aromatic amines exhibits well‐defined peaks at a potential range of +0.45 to +0.78 V on a glassy carbon electrode. Optimum working potentials for amperometric detection were from 0.70 V to +1.0 V vs. Ag/AgCl. Analytical curves for all the aromatic amines studied using the best experimental conditions present linear relationship from 1×10^?8 mol L^?1 to 1.5×10^?5 mol L^?1, r=0.99965, n=15. Detection limits of 4.5 nM (benzidine), 1.94 nM (o‐toluidine), 7.69 nM (3,3‐dimethylbenzidine), and 5.15 nM (3,3‐dichlorobenzidine) were achieved, respectively. The detection limits were around 10 times lower than that verified for HPLC with ultra violet detection. The applicability of the method was demonstrated by the determination of benzidine in wastewater from the textile industry dealing with an azo dye processing plant.     

Preparative Separation and Analysis of Complex Mixtures of Leucomycins and Desmycarosyl Leucomycins Using HPLC and Mass Spectrometry

Composition and hydrolysis products of a biotechnical available complex of macrolides were analyzed by HPLC and ESI-CID-MSⁿ. Major components are leucomycin-type antibiotics (leucomycins A₁ (5), A₇ (3), A₉ (2), 9-desoxy-9-oxo-turimycin H₃ (4) and niddamycin B (6). Hydrolysis of the complex mixture yielded 9-, 13-isoforocidins (7, 8, 9, 11) and 9-oxo-forocidin (10). A preparative separation procedure was elaborated furnishing compounds 3 - 11 for semisynthetic experiments.Prof. Dr. Udo Gräfe deceased on 14.2.2003. For obituarity see: Schlegel B (2003) J Peptide Sci 9: 661–661.     

A Fast,Simple Method for Analysis of Phenoxy Acid Salt and Ester Formulations by High Performance Liquid Chromatography

Abstract

Salt formulations of 2,4-D (2,4-dichlorophenoxyacetic acid), 2,4,5-T (2,4,5-trichlorophenoxyacetic acid) and dichlorprop [2-(2,4-dichlorophenoxy)propanoic acid] have been analysed by reversed-phase HPLC using a C18-column with 50:50 (v/v) acetonitrile/2% acetic acid as eluant. Internal and external standard HPLC methods are compared.

Ester formulations of 2,4-D and 2,4,5–T are analysed, without hydrolysis, on the same column using 60:40 (v/v) acetonitrile/2% acetic acid as eluant. The method has been used in this laboratory to determine free phenoxy acid in ester formulations, and for the identification of esters in mixed ester formulations.

The methods are fast and accurate, and offer some advantages over previously-described methods.     

Determination of Low Molecular Weight Carboxylic Acids in Water by HPLC with Conductivity Detection

Abstract

Low molecular weight carboxylic acids (C₂-C₈) were measured in aqueous samples using reverse phase HPLC coupled with conductivity detection. The aqueous samples are adjusted to pH 2 with H₂SO₄ and extracted with diethyl ether. The ether is allowed to evaporate over distilled water. The acid concentrate is analysed using a Zorbax-ODS column (25 mm × 4.6 mm). The method is simple, fast, and because of the selectivity of the conductivity detector, is relatively free from interferences. Average precision is estimated to be approximately ± 13% for the overall method.